Medicare Enrolled
Dr. Duncan Lahtinen, DO
Family Medicine · Spokane, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lahtinen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lahtinen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lahtinen
Dr. Duncan Lahtinen is a family medicine specialist in Spokane, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lahtinen performed 1,813 Medicare services across 693 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lahtinen received a total of $22,824 from 80 pharmaceutical and/or device companies across 1431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lahtinen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in WA
$22,824 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,813
Medicare services
Top 5% in WA for family medicine
693
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~95 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
789 | $62 | $125 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
166 | $43 | $75 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
158 | $0 | $3 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
148 | $1 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
127 | $62 | $162 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
116 | $121 | $121 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
104 | $38 | $104 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
92 | $9 | $21 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
67 | $10 | $40 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
23 | $2 | $11 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
12 | $21 | $52 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
11 | $9 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,824
Total received (2018-2024)
Avg $3,261/year across 7 years
Top 1% in WA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,431
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,516 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$308 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,320
2023
$4,781
2022
$4,003
2021
$2,953
2020
$2,380
2019
$2,170
2018
$2,216
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$455
ABBVIE INC.
$426
AstraZeneca Pharmaceuticals LP
$333
Sekisui Diagnostics, LLC
$250
Janssen Pharmaceuticals, Inc
$223
Boehringer Ingelheim Pharmaceuticals, Inc.
$223
Amgen Inc.
$201
PFIZER INC.
$181
GlaxoSmithKline, LLC.
$153
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$153
Lilly USA, LLC
$153
Exact Sciences Corporation
$151
Novo Nordisk Inc
$134
Otsuka America Pharmaceutical, Inc.
$125
Corcept Therapeutics
$115
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$109
Abbott Laboratories
$86
Astellas Pharma US Inc
$84
ViiV Healthcare Company
$73
Lundbeck LLC
$70
Bayer Healthcare Pharmaceuticals Inc.
$62
E.R. Squibb & Sons, L.L.C.
$51
Eisai Inc.
$47
Collegium Pharmaceutical, Inc.
$44
Becton, Dickinson and Company
$42
Sumitomo Pharma America, Inc.
$39
United Therapeutics Corporation
$39
Takeda Pharmaceuticals U.S.A., Inc.
$37
Xeris Pharmaceuticals, Inc.
$37
Novartis Pharmaceuticals Corporation
$37
Dexcom, Inc.
$36
Nevro Corp.
$34
Paratek Pharmaceuticals, Inc.
$31
Grifols USA, LLC
$20
Alnylam Pharmaceuticals Inc.
$19
Edwards Lifesciences Corporation
$18
GENZYME CORPORATION
$16
Otsuka Pharmaceutical Development & Commercialization, Inc.
$13
Top 3 companies account for 28.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,109
AstraZeneca Pharmaceuticals LP
$1,960
PFIZER INC.
$1,589
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,401
GlaxoSmithKline, LLC.
$1,347
Teva Pharmaceuticals USA, Inc.
$1,258
Janssen Pharmaceuticals, Inc
$1,219
ABBVIE INC.
$1,162
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$960
Sekisui Diagnostics, LLC
$880
Lilly USA, LLC
$869
Novo Nordisk Inc
$766
Astellas Pharma US Inc
$552
Novartis Pharmaceuticals Corporation
$512
SANOFI-AVENTIS U.S. LLC
$386
Otsuka America Pharmaceutical, Inc.
$373
Exact Sciences Corporation
$355
Abbott Laboratories
$347
Corcept Therapeutics
$333
AbbVie Inc.
$294
Amarin Pharma Inc.
$235
Merck Sharp & Dohme LLC
$231
E.R. Squibb & Sons, L.L.C.
$190
Takeda Pharmaceuticals U.S.A., Inc.
$188
Medtronic, Inc.
$170
AbbVie, Inc.
$160
Merck Sharp & Dohme Corporation
$154
Allergan, Inc.
$139
Vanda Pharmaceuticals Inc.
$126
Lundbeck LLC
$124
Allergan Inc.
$123
Eisai Inc.
$114
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$109
Gilead Sciences, Inc.
$106
Grifols USA, LLC
$102
Bayer HealthCare Pharmaceuticals Inc.
$102
Collegium Pharmaceutical, Inc.
$99
Bayer Healthcare Pharmaceuticals Inc.
$96
Becton, Dickinson and Company
$92
GENZYME CORPORATION
$89
Supernus Pharmaceuticals, Inc.
$75
Nevro Corp.
$74
ViiV Healthcare Company
$73
Radius Health, Inc.
$72
Antares Pharma, Inc.
$68
Avanir Pharmaceuticals, Inc.
$67
Kyowa Kirin, Inc.
$57
Hologic, LLC
$53
Dexcom, Inc.
$49
Phadia US Inc.
$48
Horizon Therapeutics plc
$48
Genentech USA, Inc.
$43
Sumitomo Pharma America, Inc.
$39
United Therapeutics Corporation
$39
Neurocrine Biosciences, Inc.
$39
SANOFI PASTEUR INC.
$38
Xeris Pharmaceuticals, Inc.
$37
Sunovion Pharmaceuticals Inc.
$37
Upsher-Smith Laboratories LLC
$33
Paratek Pharmaceuticals, Inc.
$31
Almatica Pharma LLC
$26
Boston Scientific Corporation
$25
Sanofi Pasteur Inc.
$25
Kowa Pharmaceuticals America, Inc.
$25
Purdue Pharma L.P.
$25
Biohaven Pharmaceuticals, Inc.
$24
Corium, LLC
$21
Bardy Diagnostics, Inc.
$21
Ultragenyx Pharmaceutical Inc.
$20
Flexion Therapeutics, Inc.
$20
Hologic Sales and Service, LLC
$20
Alnylam Pharmaceuticals Inc.
$19
Horizon Pharma plc
$18
Edwards Lifesciences Corporation
$18
Daiichi Sankyo Inc.
$17
Axsome Therapeutics, Inc.
$15
Bioventus LLC
$15
Otsuka Pharmaceutical Development & Commercialization, Inc.
$13
TherapeuticsMD, Inc.
$12
Quidel Corporation
$4
Top 3 companies account for 24.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACTIVOS 10 BONE CEMENT · ADVAIR · AIMOVIG · AIRSUPRA · AJOVY · ANNOVERA · ANORO · ANORO ELLIPTA · APRETUDE · APTIMA · AUSTEDO · Aimovig · Amitiza · Aptima Combo 2 · Austedo XR · Auvelity · Azstarys · BASAGLAR · BD SafetyGlide · BELSOMRA · BEXSERO · BREO · BREZTRI · Belbuca · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · Carnation Ambulatory Monitor · Cologuard Collection Kit · Crysvita · Dayvigo · Dexcom G6 Transmitter · Durolane · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Entyvio · Epclusa · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · GRALISE · GVOKE HYPOPEN · HETLIOZ · HYSINGLA ER · Humira · INGREZZA · INVEGA SUSTENNA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · Leqembi · Livalo · MAVYRET · MENQUADFI · MINIMED 530G · MINIMED 780G · MOUNJARO · MYFEMBREE · MYRBETRIQ · Mavyret · Morphabond ER · Myrbetriq · NEXVIAZYME · NO PRODUCT DISCUSSED · NOCDURNA · NUCALA · NUEDEXTA · NURTEC ODT · NUZYRA · Nuedexta · OFEV · ORIAHNN · ORILISSA · OTREXUP · OXLUMO · Orilissa · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PREVNAR 13 · PREVNAR 20 · Prolastin-C Liquid · Prolia · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QVAR · RECORLEV · RELISTOR · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SERTRALINE HCL · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNTHROID · Senza · Senza Spinal Cord Stimulation System · Sofia2 · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TRUMENBA · Tresiba · Trintellix · Tymlos · UBRELVY · UZEDY · VERQUVO · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · XTAMPZA · XYOSTED · Xofluza · Zembrace SymTouch Sumatriptan Injection · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in WA.
Geographic Context
Family medicine physicians within 10 mi
379
Per 100K population
69.6
County median income
$73,513
Nearest hospital
SPOKANE VA MEDICAL CENTER
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lahtinen is a clinical cardiology specialist, with above-average Medicare volume (top 5% in WA), with low-engagement industry engagement in the top 1% of WA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lahtinen experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lahtinen performed 789 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lahtinen receive payments from pharmaceutical companies?
Yes. Dr. Lahtinen received a total of $22,824 from 80 companies across 1,431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lahtinen's costs compare to other family medicine physicians in Spokane?
Dr. Lahtinen's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lahtinen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Spokane
Browse family medicine physicians in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in WA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in WA
Which WA family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology